Catapult Your Cell Therapy Research Into the Clinic: CAR NK Cells and Tregs

Explore cutting-edge solutions for advancing CAR NK cell and Treg-based therapies from basic research to clinical applications in this 43-minute webinar presented by Dr. Julia Hengst, Dr. Martha Elia Luevano Salinas, and Dr. Alina Steinbach from Miltenyi Biotec. Discover products, tools, and services that leverage Miltenyi Biotec's expertise to propel CAR NK and Treg projects forward. Learn about the latest developments in innate immune responses, engineered cells, and flow sorting applications from these experienced researchers and product managers. Gain valuable insights into transitioning cell therapy research into clinical settings, with a focus on natural killer cells and regulatory T cells. Ideal for immunologists, cancer researchers, and cell therapy developers looking to bridge the gap between laboratory discoveries and clinical implementation.